ClearPoint Neuro to Announce Third Quarter 2026 Results October 28
ClearPoint Neuro, Inc. announced today it will release its third quarter 2026 financial results on Wednesday, October 28, 2026, after market close. Investors and analysts are invited to listen to the earnings review.
ClearPoint Neuro, Inc. (NASDAQ:CLPT), a company providing precise navigation to the brain and spine, announced on Wednesday, October 14, 2026, that it will release its financial results for the third quarter of 2026 after the market closes on Wednesday, October 28, 2026.
Investors and analysts are invited to listen to a live broadcast review of the Company's third quarter results on Wednesday, October 28, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). Telephone participation will also be available.
ClearPoint Neuro is a global device, cell, and gene therapy-enabling company offering precise navigation to the central nervous system. The company's flagship product, the ClearPoint Neuro Navigation System, holds FDA clearance and CE-mark.
Thousands of procedures have been supported to date by the company's field-based clinical specialist team, which offers support and services to its customers and partners worldwide.